z-logo
open-access-imgOpen Access
<p>MDM2 promotes epithelial&ndash;mesenchymal transition through activation of Smad2/3 signaling pathway in lung adenocarcinoma</p>
Author(s) -
Yong Tang,
Yiwen Xuan,
Guibin Qiao,
Zhu’an Ou,
Zhe He,
Quangang Zhu,
Ming Juan Liao,
Guilin Yin
Publication year - 2019
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s185076
Subject(s) - epithelial–mesenchymal transition , mdm2 , gene knockdown , a549 cell , cancer research , vimentin , transfection , smad , gene silencing , small interfering rna , downregulation and upregulation , signal transduction , biology , cell growth , chemistry , apoptosis , cell culture , microbiology and biotechnology , immunology , biochemistry , gene , immunohistochemistry , genetics
Mouse double minute 2 (MDM2) contributes to cancer metastasis and epithelial-mesenchymal transition (EMT). This study aimed to investigate small mothers against decapentaplegic (Smad) signaling in MDM2-mediated EMT in lung adenocarcinoma (LAC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here